1 asset in Linear Nevus Sebaceous Syndrome
Therapeutic assets addressing Linear Nevus Sebaceous Syndrome, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Nedometinib Linear Nevus Sebaceous Syndrome | Albert Chiou | P2 | CCC (53) |